Reaktion #1744501

ord-ccb45128317b419999363c2ba9a33c27

Reaktionsbedingungen

Detaillierte Bedingungen
See reaction.notes.procedure_details.

Aufarbeitung

  1. 1
    workup.STIRRINGAfter 30 minutes of stirring at the same temperature
  2. 2
    Sonstigethe reaction mixture was evaporated in vacuo
  3. 3
    workup.ADDITIONThe residue was diluted with a mixture of tetrahydrofuran and ethyl acetate (1:3, 20 ml)
  4. 4
    Waschenwashed with brine
  5. 5
    Trocknendried over anhydrous magnesium sulfate
  6. 6
    Sonstigeevaporated in vacuo
  7. 7
    SonstigeThe residue was purified by silica gel column chromatography (3% -methanol-chloroform)

Vorschrift

To a solution of 3,4-dihydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]pyrimido[1,6-a]indol-1(2H)-one (343 mg) in N,N-dimethylformamide (20 ml) was added sodium hydride (60% in mineral oil, 51.3 mg) at 5° C. and the mixture was stirred at the same temperature for 30 minutes. Methyl iodide (182 mg) in N,N-dimethylformamide (10 ml) was added dropwise to the solution at 50° C. during 2 hours. After 30 minutes of stirring at the same temperature, the reaction mixture was evaporated in vacuo. The residue was diluted with a mixture of tetrahydrofuran and ethyl acetate (1:3, 20 ml), washed with brine, dried over anhydrous magnesium sulfate and evaporated in vacuo. The residue was purified by silica gel column chromatography (3% -methanol-chloroform) to give 3,4-dihydro-5-methyl-2-[(1,5-dimethylimidazol-4-yl)methyl]pyrimido[1,6-a]indol-1(2H)-one as crystal. The crystal was dissolved with 2N-hydrochloric acid (2 ml) and evaporated in vacuo. The crystalline residue was washed with acetone to give 3,4-dihydro-5-methyl-2-[(1,5-dimethylimidazol-4-yl)methyl]pyrimido[1,6-a]indol-1-(2H)one hydrochloride (0.2 g).

Quelle

DOI: 10.6084/m9.figshare.5104873.v1Patent: US05256780uspto-grants-1993_10